CAS: 4853-74-1; 2-(Methylsulfonyl)Propane

该化合物是一种有机硫化合物,其特征是其全氟辛烷磺酸功能组,具有显著的化学稳定性和极性;该化合物由于能够溶解广泛的极地和非极地物质,通常用作溶剂或有机合成中的中间剂;其高热性和氧化性稳定性使其适合于需要强力反应条件的应用;此外,异丙基甲基硫酮的毒性较低,而且符合工业安全标准,具有有利的环境特征;其在制药和特殊化学制造中的多功能突出地表明其作为合成途径的可靠试剂或加工辅助剂的效用.

结构式图片

相似化合物

594-43-4 595-50-6 14094-12-3

上下游产品

CAS号1551-21-9 甲基异丙基硫醚

合成工艺路线路线简述

    📜甲基异丙基硫醚置于双氧水,溶剂黄146体系中,化学反应生成 异丙基甲基砜
    参考文献:The Preparation And Properties Of Sulfur Compounds Related To Petroleum. I. The Dialkyl Sulfides And Disulfides1
    标题:The Preparation And Properties Of Sulfur Compounds Related To Petroleum. I. The Dialkyl Sulfides And Disulfides1
    摘要:
    DOI:10.1021/ja01152A021

    海关参考信息

    专利信息


    专利号:US-2005119332-A1
    优先权日:1998-03-12
    标 题 :Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases)
    发明人:JEPPESEN LONE; ANDERSEN HENRIK S; OLSEN OLE H; JUDGE LUKE M; HOLSWORTH DANIEL D; BAKIR FARID; AXE FRANK U; GE YU
    摘要:The present invention provides novel compounds of formula 1a, n nnovel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

    专利号:US-2002165398-A1
    优先权日:1998-03-12
    标题:Modulators of protein tyrosine phosphatases (PTPases)
    发明人:JEPPESEN LONE; ANDERSEN HENRIK SUNE; OLSEN OLE HVILSTED; JUDGE LUKE MILBURN; HOLSWORTH DANIEL DALE; BAKIR FARID; AXE FRANK URBAN; GE YU
    摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. n The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimers disease and schizophrenia, and infectious diseases.

    专利号:US-2024262834-A1
    优先权日:2021-05-28
    标 题:Synthesis of btk inhibitor and intermediates thereof
    发明人:CHEN YONGGANG; CORRY JAMES; DESMOND RICHARD; DI MASO MICHAEL J; FORSTATER JACOB H; KUETHE JEFFREY T; KUHL NADINE; LARSON REED; LEVESQUE FRANCOIS; NARSIMHAN KARTHIK; OTTE DOUGLAS; PRIER CHRISTOPHER K; SHEVLIN MICHAEL; SIROTA ERIC; TAN LUSHI; THAISRIVONGS DAVID A; TURNBULL BEN W H; WANG ZHIXUN; XIAO KAIJIONG
    权利人:MERCK SHARP & DOHME LLC
    摘要:The present invention relates to efficient synthetic processes useful in the preparation of Compound A, a BTK inhibitor of Formula (I): or a pharmaceutically acceptable salt thereof, including the preparation of intermediates used to make Compound A or a pharmaceutically acceptable salt thereof.

    专利号:US-8691972-B2
    优先权日:2009-05-29
    标 题 :Compounds and synthesis of tellurium-derivatized oligonucleotides for structural and functional studies
    发明人:HUANG ZHEN
    权利人:HUANG ZHEN
    摘要:Disclosed are compounds of formula (I), a derivative, or a tautomer thereof, or a pharmaceutically acceptable salt of said compound or said tautomer. Also disclosed are methods of preparing compound of formula (I), a derivative, or a tautomer thereof, or a pharmaceutically acceptable salt of said compound or said tautomer. Further disclosed are methods of counducting drug discovery and research comprises applying the compound of formula (I), a derivative, or a tautomer thereof, or a pharmaceutically acceptable salt of said compound or said tautomer in an investigation.

    专利号:US-7598399-B2
    优先权日:2005-11-30
    标 题 :Methods for synthesis of 3-amino-1-arylpropyl indoles
    发明人:CONNOLLY TERRENCE JOSEPH; FARRELL ROBERT P; HUMPHREYS ERIC ROY; LYNCH STEPHEN M; SARMA KESHAB
    权利人:ROCHE PALO ALTO LLC
    摘要:A method comprising:n hydrogenating an indole propionamide compound of formula h nn nwith vitride, to form an aminopropyl indole compound of formula in n nwherein m, Ar, R 1 and R 2 are as defined herein. The compounds prepared by the method of the invention are useful as monoamine reuptake inhibitors useful for treatment of CNS indications.

    专利号:US-9303041-B2
    优先权日:2012-08-21
    标题 :Haptens of olanzapine
    发明人:DONAHUE MATTHEW GARRETT; GONG YONG; SALTER RHYS; HRYHORENKO ERIC; DECORY THOMAS R; REMMERIE BART; SANKARAN BANUMATHI
    权利人:JANSSEN PHARMACEUTICA NV; ORTHO CLINICAL DIAGNOSTICS INC
    摘要:The invention relates to compounds of Formula I, wherein R 1 , R 2 , and R 3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from olanzapine. The invention also relates to conjugates of an olanzapine hapten and a protein.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s11705-018-1758-z
    摘要:Zhang T, Paillard E. Recent advances toward high voltage, EC-free electrolytes for graphite-based Li-ion battery. Frontiers of Chemical Science and Engineering. 2018 Sep;12(3):577–91. doi: 10.1007/s11705-018-1758-z.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知